BusinessCempra to Present Solithromycin at FDA Antimicrobial Drugs Advisory Committee Meeting on November 4, 2016By Nasdaq OMXAug 30, 2016, 1:15 PM UTC
BusinessCempra to Participate in Nature's Webcast on Combating Antibiotic Resistance on March 9By Nasdaq OMXMar 8, 2016, 9:10 PM UTC
BusinessCempra to Report Fourth Quarter and Full Year 2015 Financial ResultsBy Nasdaq OMXFeb 17, 2016, 12:30 PM UTC
BusinessCempra to Ring NASDAQ Closing Bell to Mark 10th AnniversaryBy Nasdaq OMXJan 26, 2016, 1:00 PM UTC
BusinessParatek Accelerates Timing for Projected Reporting of Top-Line Data for Omadacycline Phase 3 Skin TrialBy Nasdaq OMXJan 6, 2016, 12:00 PM UTC
